What is AOR?
Founded in 1991, Advanced Orthomolecular Research (AOR) is a prominent entity in the natural health sector, dedicated to developing evidence-based products. The company focuses on formulations that support critical bodily systems, including cardiovascular, cognitive, digestive, and immune functions. AOR distinguishes itself through a commitment to scientific integrity, often partnering with research institutions to validate its innovative product lines. Their offerings, available in various forms such as capsules, powders, and softgels, are designed to meet diverse health needs and dietary requirements, emphasizing transparency and high-quality manufacturing standards.
How much funding has AOR raised?
AOR has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in AOR
PPP
Public-Private Partnership
What's next for AOR?
The substantial capital infusion, particularly the recent strategic investment, suggests AOR is poised for accelerated expansion and potentially further product development or market reach. As a company operating in the large-scale late-stage funding arena, AOR is likely focused on scaling operations, enhancing its distribution networks, and solidifying its market leadership in the evidence-based natural health products industry. Future strategic moves may involve deeper integration of research findings into new product lines or expanding into new geographical markets.
See full AOR company page
